Improved remission rates with the IL-6R inhibitor tocilizumab (TCZ) in patients with active rheumatoid arthritis despite DMARD therapy: The toward study Genovese, M. C., Mckay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., Laughton, J., Eves, D., Gomez-Reino, J. J. OXFORD UNIV PRESS. 2008: II50

View details for Web of Science ID 000254680900169